Sudden cardiac arrest in takotsubo cardiomyopathy - a case study.

Postepy Kardiol Interwencyjnej

First Clinical Department of Cardiology and Electrotherapy, Świętokrzyskie Cardiology Center, Kielce, Poland ; Faculty of Health Sciences, Jan Kochanowski University, Kielce, Poland.

Published: July 2014

We present a 59-year-old woman who was admitted to hospital after sudden cardiac arrest due to ventricular fibrillation. Finally takotsubo syndrome was diagnosed. In the acute phase of takotsubo syndrome life-threatening ventricular arrhythmias and significant hemodynamic disorders may occur due to strong adrenergic stimulation and myocardial ischemia. It has been proved that the occurrence of torsade de pointes tachycardia in the acute phase of takotsubo cardiomyopathy is associated with QT prolongation. There are no clear guidelines on pharmacological treatment and implantable cardioverter defibrillator implantation after a past takotsubo episode. Takotsubo cardiomyopathy has not been entirely explained as an etiological disease.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4108735PMC
http://dx.doi.org/10.5114/pwki.2014.43517DOI Listing

Publication Analysis

Top Keywords

takotsubo cardiomyopathy
12
sudden cardiac
8
cardiac arrest
8
takotsubo syndrome
8
acute phase
8
phase takotsubo
8
takotsubo
6
arrest takotsubo
4
cardiomyopathy case
4
case study
4

Similar Publications

Bibliometric analysis of levosimendan.

Int J Cardiol Heart Vasc

February 2025

Department of Anesthesiology, Fuwai Hospital, National Center for Cardiovascular Diseases, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, China.

Background: Levosimendan (LEVO), a calcium sensitizer and adenosine triphosphate-dependent potassium channel opener, has been widely used for decades in medical and surgical patients for advanced heart failure (HF), right ventricular failure, cardiogenic shock, takotsubo cardiomyopathy, pulmonary hypertension, and so on. Currently, as the limited scope and lack of comprehensive data in current LEVO publications, there is an increasing obstacle to conducting new studies that require integrated information and quantifiable results. Thus, the current study was performed to identify the research trends and hot spots in LEVO-related publications using bibliometric software.

View Article and Find Full Text PDF

We present a case of a 73-year-old woman with a medical history significant for hyperlipidemia, on pravastatin, who developed Takotsubo cardiomyopathy following a diagnosis of osteoporosis. She presented to the Emergency Department with acute transient left arm pain that resolved spontaneously. Investigations revealed elevated troponin levels, non-specific electrocardiographic changes, no significant coronary artery disease on angiography, and left ventricular systolic dysfunction, findings consistent with Takotsubo cardiomyopathy.

View Article and Find Full Text PDF

We present a case of a 52-year-old male with no known past medical history who presented to an outside hospital with acute chest pain. Initial workup revealed anteroseptal ST-elevation myocardial infarction (STEMI) for which the patient was transferred to our facility for emergent percutaneous coronary intervention (PCI). However, the patient's hospital course revealed numerous confounding pathologies that can also present as STEMI, including transthoracic echocardiogram (TTE) abnormalities consistent with takotsubo cardiomyopathy (TCM) as well as myocardial bridging presenting as post-PCI STEMI in the setting of nitroglycerin use.

View Article and Find Full Text PDF

Commentary on "Did Jesus Die of Takotsubo Cardiomyopathy? A Medical Revisiting of the Gospels.

J Gen Intern Med

January 2025

Surgical Sciences of the Developmental Age, President AMCI Campania Region (Italian Catholic Doctors Association), Campania, Italy.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!